Tradestie Institutional Equity Comparison Engine
INFU vs DXR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INFU Overall Edge
INFU Captures Institutional Edge (4โ0 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to InfuSystem Holdings, Inc. (INFU) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INFU trades at 26.4x Forward P/E with 8.5% operating margin (+3.0% YoY revenue) versus DXR at 64.5x Forward P/E and -5894.3% operating margin (+25.5% YoY). In options structure, INFU sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
INFU
INFU 26.4x vs DXR 64.5x Fwd P/E
Growth & Margin Winner
INFU
Op Margin 8.5% vs -5894.3% ยท YoY +3.0% vs +25.5%
Momentum & Technical Winner
INFU
1Y +45.6% vs -38.3% ยท 52W Pos 92% vs 2%
Options & Structure Winner
INFU
CONSOLIDATION (7th %ile IV) vs UNCLASSIFIED (N/A IV)
INFU
NYSE American
InfuSystem Holdings, Inc.
Surgical & Medical Instruments & Apparatus
$14.79
+0.48% 1D
Market Cap
$294.9M
1M Return
+10.37%
1Y Return
+45.57%
Forward P/E
26.4x
Unified AI Score
36.6 / 100
SELL
Tech 8.0
Fund 28.0
Flow 54.0
Mom 25.9
DXR
NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap
$49.5M
1M Return
-16.87%
1Y Return
-38.29%
Forward P/E
64.5x
Unified AI Score
52.2 / 100
HOLD
Tech 52.0
Fund 59.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
INFU +45.57%
DXR -38.29%
Spread: +78.84 pp (INFU Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
INFU TTM Op. Margin: 8.5%
DXR TTM Op. Margin: -5894.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INFU vs DXR. Trailing 12-month operating profitability (INFU 8.5% vs DXR -5894.3%) and valuation multiples (INFU 26.4x vs DXR 64.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | INFU | DXR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $294.9M | $49.5M | Larger Scale | INFU |
| Trailing P/E Ratio Valuation | 33.5x | 7.7x | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | 26.4x | 64.5x | Lower Multiple | INFU |
| Revenue Growth (YoY) Growth | +3.0% | +25.5% | Higher Growth | DXR |
| Operating Margin (TTM) Profitability | 8.5% | -5894.3% | Higher Margin | INFU |
| Net Profit Margin Profitability | 6.5% | 19861.4% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | 15.8% | 14.2% | Higher ROE | INFU |
| 52-Week Range Position Momentum | 92% ($7โ$15) | 2% ($8โ$15) | Stronger Trend | INFU |
| Beta / 30D Volatility Risk Regime | 0.78ฮฒ ยท 48% Vol | 0.28ฮฒ ยท 32% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 36.6 / 100 (SELL) | 52.2 / 100 (HOLD) | Higher Composite | DXR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full INFU vs DXR Buy Guide
INFU
CONSOLIDATION
22d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
DXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither INFU nor DXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.